The Adolescent Interventions to Manage Self-Regulation of T1D (AIMS T1D) project studies whether self-regulation interventions can enhance self-regulation targets and medical regimen adherence behaviors in adolescents with type 1 diabetes.
The self-regulation targets include Executive Function (EF), Emotion Regulation (ER) and Future Orientation (FO). Diabetes related health outcomes include HbA1c and quality of life.
Ninety-four youth between 13.0 and 17.99 years will be enrolled in this RCT (ClinicalTrials.gov NCT03688919), funded through the NIH Common Fund/Office of Behavioral and Social Sciences Research/Science of Behavior Change Initiative (UH3HD087979).
Dr. Emily Fredericks, Department of Pediatrics and Communicable Diseases, is multiple PI on this study along with Dr. Miller. Co-Investigators include Joyce Lee and Dana Albright from the Department of Pediatrics and Communicable Diseases, Kate Bauer, School of Public Health, and Niko Kaciroti, Center for Human Growth and Development.
AIMS Parents is a related study to AIMS T1D. The objective is to examine associations between parents’ self-regulation (SR), youth management of type 1 diabetes (T1D), and youth T1D outcomes.
To this end, we will examine associations between parents’ SR, youth treatment regimen adherence, and youth T1D outcomes and examine how parents’ SR is related to key diabetes-relevant family processes known to support youth T1D treatment regimen adherence and glycemic control.
Parents or legal guardians of youth (ages 11.0-17.99, with T1D for at least 6 months) are the primary focus of this study.
To learn more about the AIMS T1D studies, please read the AIMS Newsletter.